BCYC Q1 2022 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+113.5% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$27M-709.4% margin

Net Income

-$28M-714.1% margin

EPS (Diluted)

$-0.93

QoQ Revenue Growth

+2.4%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$31M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$460M

Total Liabilities

$129M

Stockholders' Equity

$330M

Cash & Equivalents

$407M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+113.5%
Gross Profit	$4M	$2M	+113.5%
Operating Income	-$27M	-$16M	-70.9%
Net Income	-$28M	-$16M	-70.2%